Advanced Stage
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| First-line Combination Treatment Based on Anlotinib (NCT03628521) | Shanghai Chest Hospital | 2018-07-20 |
Track Advanced Stage automatically
Every clearance here is in the API, with alerts when new ones post.